We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.03%
3 Healthcare 14.17%
4 Industrials 13.91%
5 Financials 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMNB icon
551
Farmers National Banc Corp
FMNB
$930M
$409K 0.07%
30,831
+8,994
+41% +$112K
FOUR icon
552
Shift4
FOUR
$3.26B
$409K 0.07%
+5,426
New +$325K
ONTO icon
553
Onto Innovation
ONTO
$15.3B
$409K 0.07%
8,597
+756
+10% +$30.3K
UPST icon
554
Upstart Holdings
UPST
$3.03B
$408K 0.07%
+10,000
New +$411K
IMDX
555
Insight Molecular Diagnostics
IMDX
$156M
$407K 0.07%
8,507
-1,545
-15% -$56.7K
PAHC icon
556
Phibro Animal Health
PAHC
$1.39B
$407K 0.07%
20,961
+5,309
+34% +$97.7K
TXNM
557
TXNM Energy Inc
TXNM
$5.94B
$407K 0.07%
8,386
-4,448
-35% -$215K
EHC icon
558
Encompass Health
EHC
$12.4B
$406K 0.07%
6,176
-150
-2% -$8.82K
AROC icon
559
Archrock
AROC
$5.8B
$405K 0.07%
+46,722
New +$341K
CERT icon
560
Certara
CERT
$1.25B
$405K 0.07%
+12,000
New +$439K
K
561
DELISTED
Kellanova
K
$405K 0.07%
6,934
+1,082
+18% +$65K
GM icon
562
General Motors
GM
$76.8B
$404K 0.07%
9,708
-2,649
-21% -$103K
GIS icon
563
General Mills
GIS
$19.7B
$403K 0.07%
+6,862
New +$415K
MBUU icon
564
Malibu Boats
MBUU
$567M
$403K 0.07%
+6,449
New +$372K
WERN icon
565
Werner Enterprises
WERN
$2.25B
$403K 0.07%
10,273
-22,397
-69% -$911K
AEO icon
566
American Eagle Outfitters
AEO
$3.01B
$402K 0.07%
20,029
-85
-0.4% -$1.43K
BILI icon
567
Bilibili
BILI
$7.84B
$402K 0.07%
4,691
-8,981
-66% -$526K
CHE icon
568
Chemed
CHE
$7.22B
$402K 0.07%
754
-1,694
-69% -$832K
NPTN
569
DELISTED
NEOPHOTONICS CORP
NPTN
$401K 0.07%
44,146
+2,768
+7% +$21.4K
ARCO icon
570
Arcos Dorados Holdings
ARCO
$1.74B
$399K 0.07%
80,554
-34,629
-30% -$158K
CVX icon
571
Chevron
CVX
$366B
$399K 0.07%
+4,719
New +$382K
TAP icon
572
Molson Coors Class B
TAP
$8.09B
$399K 0.07%
8,833
+1,827
+26% +$75.3K
VV icon
573
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$399K 0.07%
+2,269
New +$377K
BLPH
574
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$397K 0.06%
59,589
+31,497
+112% +$258K
G icon
575
Genpact
G
$5.76B
$396K 0.06%
9,579
-11,361
-54% -$449K

Similar funds

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.